2013
DOI: 10.1093/eurjhf/hft016
|View full text |Cite
|
Sign up to set email alerts
|

Corrigendum to: ‘ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012’ [Eur J Heart Fail 2012;14: 803–869]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
199
0
12

Year Published

2013
2013
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 158 publications
(213 citation statements)
references
References 0 publications
2
199
0
12
Order By: Relevance
“…In line with other studies (5,19), participants described random periods of stability and decline of variable lengths. In this study occupational performance is also highlighted as changing on a day-to-day basis.…”
Section: Discussionsupporting
confidence: 64%
See 1 more Smart Citation
“…In line with other studies (5,19), participants described random periods of stability and decline of variable lengths. In this study occupational performance is also highlighted as changing on a day-to-day basis.…”
Section: Discussionsupporting
confidence: 64%
“…Symptoms such as breathlessness and fatigue are characteristic (5). In the elderly with CHF, physical rather than mental fatigue seems to have negative impact on activities of daily living (4), but comorbidities and normal ageing must also be considered (5).…”
mentioning
confidence: 99%
“…Underestimation of comorbidity and the inherent complexity of the requisite treatments may hamper efforts to implement depression screening guidelines into clinical practice [1,22]. Notwithstanding the dearth of clinical guidance on depression treatment plans when comorbid anxiety is present [23], there is a paucity of evidence-based treatments for anxiety disorders in CVD.…”
Section: Discussionmentioning
confidence: 99%
“…The end stage of all cardiovascular diseases (CVD) is heart failure (HF), a complex clinical syndrome characterized by dyspnea and fatigue, and objective evidence of underlying structural abnormality or cardiac dysfunction [1]. HF is a chronic and disabling condition and survival rates are approximately 25%, five years after the first HF hospitalization [2].…”
Section: Introductionmentioning
confidence: 99%
“…Porém, atualmente assistimos a uma notória diminuição do número de dadores, principal elemento restritivo da transplantação. Nos últimos anos, a redução na oferta de dadores tem obrigado a alargar os critérios de seleção, consequentemente alterando o respetivo perfil para o de um dador de mais idade, falecido por doença neurológica e frequentemente acompanhado de outro tipo de patologias e fatores ou hábitos de risco cardiovascular 3,4 .…”
Section: Introductionunclassified